The Next-Gen HCP360: Revolutionizing Pharma Engagement

Written By - Harpreet Singh, Co - founder & Partner

The Next-Gen HCP360: Revolutionizing Pharma Engagement

Life sciences companies have made significant strides in leveraging analytics and technology to solve complex commercialization challenges. By unifying in-house data—such as prescriptions, claims, field activity, and personal and non-personal promotional channels—they are gaining valuable insights about target Health Care Professionals (HCPs). However, many organizations are still not fully utilizing the vast digital data available.

Take the 2024 ASCO conference as an example. The event generated over 42,000 tweets and amassed 2 million engagements, with 85% of interactions coming from individual oncologists or cancer speakers discussing presented studies. This data underscores the wealth of insights available in digital domains, including social media platforms and online medical forums. Leveraging such data could enable life sciences companies to achieve a deeper understanding of their customers, similar to what companies in high-tech and retail sectors enjoy.

Why Should Data and Insights Leaders Care?

The landscape of HCP engagement is shifting. Post-COVID-19, access to specialty physicians has reduced, making it challenging for field teams to secure meaningful interactions with HCPs. However, HCPs themselves are offering a pathway forward. Contrary to common belief, physicians are increasingly tech-savvy—more than 5% of physicians are active digital content creators, compared to only 1% of non-physicians.

By tapping into digital data, life sciences organizations can gain the following advantages:

1. Enhanced Customer Insights

Digital data provides a comprehensive view of HCP preferences, behaviors, and engagement patterns, including:

Types of content HCPs create, share, and engage with.
Key topics that resonate with HCPs and their evolving preferences.
Events and congresses where HCPs actively participate.

2. Improved Utilization of Network Influence

The adage “Your network is your net worth” holds true in the HCP ecosystem. Understanding an HCP's network strength unlocks numerous opportunities:

Identifying physicians who influence or are influenced by the target HCPs.
Recognizing Digital Opinion Leaders (DOLs) within the specialty.

3. Deeper Understanding of HCP Share of Voice

While traditional market research relies on small sample sizes, digital data offers broader and unbiased insights:

Insights from 15-20x larger sample sizes.
Unaided and unbiased information.
Actionable, targeted insights at the individual HCP level.

Current State of External Data Utilization

Many life sciences companies are focusing on creating a unified HCP360 view using internal data sources like sales activities, speaker bureaus, and website interactions. However, the integration of external data sources remains underutilized. Social media data is employed by a few, but even fewer organizations tap into online publications, forums, conference proceedings, and clinical trials.

Types of External Data Sources to Leverage:

Social Media Platforms: Twitter/X, LinkedIn, and YouTube, where HCPs share and discuss research.
Online Medical Journals: Peer-reviewed journals offering insights into scientific discoveries and HCP opinions.
Professional Forums: Platforms like Sermo and Doximity for HCP discussions.
Research and Clinical Trials: Comprehensive views of ongoing and upcoming research in therapies.

Challenges of Digital Data Utilization

While digital data offers immense potential, it comes with its own set of challenges:

Data Privacy and Compliance: Adhering to GDPR and HIPAA regulations.
Unstructured Data: The unstructured nature of data makes sourcing and processing resource-intensive.
Noise and Quality: Ensuring data accuracy, relevance, and timeliness requires advanced data science infrastructure.
Data Volumes: Managing and processing large data volumes demands significant investment.

Introducing Auxo: ProcDNA’s Proprietary HCP360 Solution

ProcDNA has invested in developing Auxo, a next-gen HCP360 solution combining internal and external digital data sources. Auxo empowers life sciences companies to unlock the full potential of HCP360 with:

Data from 100+ Sources: Integrated at the NPI level for a complete view of HCPs.
Advanced NLP Engine: Eliminates noise and accurately tags information to HCPs.
Integration Capabilities: Merges internal company data with Auxo’s digital data for sophisticated analytics.
Custom Solutions: Aligns with specific organizational goals to improve commercial strategies.

The Future of HCP Engagement

By leveraging Auxo’s capabilities, life sciences companies can overcome data complexities and realize the full potential of HCP360. This transformative approach enables a deeper understanding of HCPs, enhances engagement strategies, and delivers a significant competitive advantage.

How Are You Preparing for the Next-Gen HCP360?

Explore the power of digital data and redefine your approach to HCP engagement with ProcDNA.

For more information, contact us at marketing@procdna.com.